Page 35 - மனிதன் சேவைகள் செயலாளர் அலெக்ஸ் அசார் News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Josh Rogin Chaos Under Heaven excerpt: How covid hastened the decline and fall of the U S -China relationship
washingtonpost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from washingtonpost.com Daily Mail and Mail on Sunday newspapers.
Astroturf Campaign Attacks Discount Drug Program for the Poor
An antiâgovernment waste group is helping its Big Pharma funder oppose a discount drug program that doesnât cost the government a penny.
Steve Ruark/AP Images for AIDS Healthcare Foundation
Protesters rallied outside pharmaceutical firm AstraZeneca, October 14, 2020, in Wilmington, Delaware, after the company stopped offering drug discounts required by the 340B program.
Sludge produces investigative journalism on lobbying and money in politics. The American Prospect
 is re-publishing this article.
Each year, thousands of patients at medical facilities that serve the poor are given free or discounted medications through an obscure federal program that pharmaceutical companies are required to participate in as a condition of having their drugs covered by Medicare. Passed by Congress in 1992, the program, known as 340B, has come under attack from the pharmaceutical industry for being too generous to t
March 2, 2021 6:10 AM By Brandon Lee
Ambulance companies are seeking a major victory as Senate Democrats consider whether to allow Medicare to pay them as emergency responders in the field.
The proposed change, which may be added to the Covid-19 relief package the Senate is expected to take up later this week, would empower the Department of Health and Human Services to temporarily pay ambulance providers for services they deliver to Medicare beneficiaries outside a hospital. Ambulances are generally paid by Medicare only to deliver patients to an emergency room currently.
If a patient refuses to go to a hospital, which ambulance companies say is increasingly common as people are wary of health-care facilities during the pandemic, ambulances responding to a call often recoup no reimbursement from Medicare.
Biden Administration secures supply of new COVID-19 therapeutic treatment The treatment uses two monoclonal antibodies, bamlanivimab and etesevimab, to treat nonhospitalized high-risk COVID-19 patients.
, Associate Editor
As of Friday, the Biden Administration has secured a supply of a recently authorized COVID-19 therapeutic treatment, with the U.S. Department of Health and Human Services and the Department of Defense collaborating to purchase 100,000 courses of a second treatment from Eli Lilly and Company.
The treatment uses two monoclonal antibodies, bamlanivimab and etesevimab, to treat non-hospitalized, high-risk COVID-19 patients.
The U.S. Food and Drug Administration issued emergency use authorization for Eli Lilly s therapeutic of bamlanivimab and etesevimab on February 9. The treatment is administered through an intravenous infusion and is intended for nonhospitalized patients with confirmed COVID-19 who are experiencing mild to moderate symptoms and ar
Column: How Americans rose to the COVID-19 challenge
chicagotribune.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from chicagotribune.com Daily Mail and Mail on Sunday newspapers.
vimarsana © 2020. All Rights Reserved.